The development of the first nasal Covid vaccine, along with others before it, is an affirmation of India's capacity to provide solutions t...

The need of the hour is a dynamic, evidence-based approach, with involvement of public health experts and epidemiologists as guides, and to...

Researchers believe mucosal vaccines may prevent even mild cases of illness and block transmission to other people.

Earlier this month, Bharat Biotech announced that its iNCOVACC (BBV154),the world's first intranasal COVID-19 vaccine, has received approva...

It may produce local antibodies in the upper respiratory tract - which could provide the potential to reduce infection and transmission.

Nasal vaccines are administered, as the name suggests, through the nose.

The currently available Covid-19 vaccines are injected into people’s arm muscles and are highly capable at combating the virus once people ...

The trials of the Intranasal vaccine will take place at nine different sites of the country.

The subject expert committee (SEC) under India's drug regulator gave its go-ahead to Hyderabad-based Bharat Biotech to conduct the phase 2/...

This new method is unlike the currently approved COVID-19 vaccines that require an injection.

Bharat Biotech, which has developed India’s indigenous Covid-19 vaccine, Covaxin, has sought regulatory approval to start phase-1 and phase...